See original release here December 21, 2016 – HALIFAX, Nova Scotia –– Appili Therapeutics Inc. (“Appili”), an anti-infective drug development company, announced today it raised $2,151,000 in its over-subscribed private placement financing. Participants in this capital raise included current Appili investors such as Innovacorp, as well as new individual and institutional investors. Proceeds from the…

See full original release here TruLeaf Closes $8.5-million Round of Financing Former executive of Scotiabank joins TruLeaf board of directors   TORONTO, ON/BIBLE HILL, NS, December 7, 2016 – TruLeaf Sustainable Agriculture Ltd. (TruLeaf), the indoor, multi-level farming company from Bible Hill, Nova Scotia has closed an $8.5-million equity-finance round. This funding will enable the…

To see original article, click here For Immediate Release Halifax, NS -Windsor based, BioMedica Diagnostics (BMD) made the announcement today that it has purchases the specialty coagulation business and product line from Sekisui Diagnostics (SDG). The agreement includes all aspects of the business worldwide, with the exception of Europe, Middle East, and Africa, where SDGmbH,…

See original article here Ottawa, December 1, 2016 – Innovative Medicines Canada is pleased to announce the appointment of Pamela Fralick as its new President, effective immediately. Ms. Fralick comes to Innovative Medicines Canada as a proven healthcare leader, with a wealth of experience advancing critical healthcare initiatives and a deep understanding of public policy…

To see original article, click here For Immediate Release HALIFAX, Dec 1, 2016 – Tom Lynch, Chair of Precision BioLogic’s Board of Directors, is pleased to announce the appointment of Paul Empey as President and CEO of the company. Most recently Precision BioLogic’s Executive Vice President, Empey joined the organization in 2015, bringing with him…

2015 © Copyright - Bionova